TrialBMC cancer2018

Phase II study of neoadjuvant checkpoint blockade in patients with surgically resectable undifferentiated pleomorphic sarcoma and dedifferentiated liposarcoma.

Emily Z Keung et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.